Zephyr Endobronchial Valve

DEVICE3 trials

Sponsors

Heidelberg University, Hospital de Clinicas de Porto Alegre, Pulmonx Corporation

Conditions

COPDChronic Obstructive Pulmonary Disease SevereEmphysemaSevere Emphysema

Phase 2

Cell Therapy Associated With Endobronchial Valve

RecruitingNCT04018729

Hospital de Clinicas de Porto AlegreChronic Obstructive Pulmonary Disease Severe

Start: 2019-11-19End: 2029-04-30Target: 34Updated: 2022-12-14

Phase 3

Sequential Endoscopic Lung Volume Reduction

WithdrawnNCT00613860

Heidelberg UniversityCOPD, Emphysema

Start: 2008-01-31End: 2012-04-30Updated: 2022-09-02

Unknown Phase

Zephyr Valve Japan Post-Marketing Surveillance

RecruitingNCT06332885

Pulmonx CorporationCOPD, Emphysema, Severe Emphysema

Start: 2024-03-12End: 2028-03-31Target: 140Updated: 2026-09-17